Companies: 48,874 Total Market Cap: 131312068591816.79

Medicon Hellas S.A.

ATH-MEDIC
Healthcare Drug Manufacturers - Specialty & Generic
Rank #38977
Market Cap 10.95 M
Volume 3,188.20
Price 2.48
Change (%) 2.31%
Country or region Greece Greece

Medicon Hellas S.A.'s latest marketcap:

10.95 M

As of May 14, 2025, Medicon Hellas S.A.'s market capitalization has reached $10.95 M. According to our data, Medicon Hellas S.A. is the 38977th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 10.95 M
Revenue (ttm) 20.33 M
Net Income (ttm) 1.44 M
Shares Out 4.42 M
EPS (ttm) 0.35
Forward PE 0.00
Ex-Dividend Date July 15, 2024
Earnings Date April 29, 2025
Market Cap Chart
Data Updated: May 14, 2025

Medicon Hellas S.A.'s yearly market capitalization.

Medicon Hellas S.A. has seen its market value grow from €8.40 M to €9.77 M since 2020, representing a total increase of 16.32% and an annual compound growth rate (CAGR) of 3.52%.
Date Market Cap Change (%)
May 14, 2025 €9.77 M 0%
December 31, 2024 €9.55 M -35.14%
December 29, 2023 €14.72 M -10%
December 30, 2022 €16.35 M -24.18%
December 31, 2021 €21.57 M 156.84%
December 31, 2020 €8.40 M

Company Profile

About Medicon Hellas S.A.

Medicon Hellas S.A. is a leading player in the diagnostics industry, providing advanced solutions for healthcare institutions globally. Headquartered in Gerakas, Greece, the company has been serving the medical sector since its incorporation in 1988.

Core Offerings

  • Diagnostic Instruments & Tests: Supplies analyzer systems for chemistry, immunochemistry, hematology labs, intensive care units, and point-of-care applications.
  • Reagents & Testing Materials: Produces clinical chemistry reagents, control and calibration materials, and specialized tests for various analyzers.
  • Cosmetic Products: Develops and markets skincare and cosmetic products under the Miss Beaute brand.
  • Healthcare IT Solutions: Designs and sells software for laboratory and medical applications, along with IT systems for healthcare providers.
  • Remanufacturing & Services: Offers remanufactured analyzers (chemistry, hematology, blood gas, immunochemistry) and provides contract diagnostics laboratory services.

Global Reach

The company serves public and private hospitals, primary care centers, diagnostic centers, and laboratories across Greece and international markets.

Frequently Asked Questions

As of May 14, 2025, Medicon Hellas S.A. (including the parent company, if applicable) has an estimated market capitalization of $10.95 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Medicon Hellas S.A. global market capitalization ranking is approximately 38977 as of May 14, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Greece
Founded 1988
IPO Date n/a
Employees 174
CEO Dimotsantos Spyridon
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Address 5-7 Melitona Street
Gerakas, 153 44
Greece
People Also Watch
HDB
72.39 0.68%
SHA-600036
6.22 0.68%
IBN
33.52 0.68%
TADAWUL-1120
26.16 0.68%